Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
Net Income/ Starting Line | 273.32 | 314.20 | 253.37 | 233.28 |
Depreciation/ Depletion | 27.40 | 28.10 | 27.08 | 30.04 |
Non- Cash Items | 24.87 | 13.39 | 0.23 | -0.48 |
Changesin Working Capital | -97.30 | -119.70 | -111.15 | -15.58 |
Cashfrom Operating Activities | 228.29 | 235.99 | 169.53 | 247.26 |
Capital Expenditures | -21.73 | -42.48 | -37.92 | -52.58 |
Other Investing Cash Flow Items Total | 14.86 | 20.98 | 12.38 | 20.31 |
Cashfrom Investing Activities | -6.87 | -21.50 | -25.54 | -32.27 |
Total Cash Dividends Paid | -414.99 | -93.79 | -283.85 | -381.78 |
Issuance( Retirement)of Debt Net | -3.12 | -4.68 | -4.78 | -4.85 |
Cashfrom Financing Activities | -418.11 | -98.47 | -288.63 | -386.63 |
Net Changein Cash | -196.69 | 116.02 | -144.64 | -171.64 |
Cash Taxes Paid | 85.19 | 89.66 | 63.86 | 68.12 |
Financing Cash Flow Items | - | - | - | 0.00 |
Procter & Gamble Health Dividend Procter & Gamble Health Bonus Procter & Gamble Health News Procter & Gamble Health AGM Procter & Gamble Health Rights Procter & Gamble Health Splits Procter & Gamble Health Board Meetings Procter & Gamble Health Key Metrics Procter & Gamble Health Shareholdings Procter & Gamble Health Profit Loss Procter & Gamble Health Balance Sheet Procter & Gamble Health Q1 Results Procter & Gamble Health Q2 Results Procter & Gamble Health Q3 Results Procter & Gamble Health Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks